Arbutus Biopharma Corp (ABUS)
3.875
+0.02
(+0.39%)
USD |
NASDAQ |
Nov 05, 11:31
Arbutus Biopharma Price: 3.875 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 3.96 | 3.96 | 3.855 | 3.86 | 848786.0 |
| Nov 01, 2024 | 3.85 | 3.990 | 3.80 | 3.96 | 554161.0 |
| Oct 31, 2024 | 3.94 | 3.96 | 3.825 | 3.845 | 724803.0 |
| Oct 30, 2024 | 4.01 | 4.03 | 3.93 | 3.94 | 436084.0 |
| Oct 29, 2024 | 4.05 | 4.05 | 3.97 | 4.04 | 544851.0 |
| Oct 28, 2024 | 4.01 | 4.10 | 4.005 | 4.05 | 487431.0 |
| Oct 25, 2024 | 4.05 | 4.09 | 3.95 | 3.97 | 504380.0 |
| Oct 24, 2024 | 4.04 | 4.08 | 4.01 | 4.05 | 395812.0 |
| Oct 23, 2024 | 4.03 | 4.12 | 3.96 | 4.06 | 917672.0 |
| Oct 22, 2024 | 4.06 | 4.08 | 3.91 | 4.03 | 945270.0 |
| Oct 21, 2024 | 4.15 | 4.15 | 3.98 | 4.07 | 787630.0 |
| Oct 18, 2024 | 4.12 | 4.19 | 4.105 | 4.15 | 876479.0 |
| Oct 17, 2024 | 4.20 | 4.208 | 4.08 | 4.12 | 901012.0 |
| Oct 16, 2024 | 4.15 | 4.349 | 4.10 | 4.20 | 3.354M |
| Oct 15, 2024 | 3.91 | 4.12 | 3.89 | 4.11 | 1.174M |
| Oct 14, 2024 | 3.88 | 3.90 | 3.83 | 3.86 | 423513.0 |
| Oct 11, 2024 | 3.79 | 3.90 | 3.79 | 3.88 | 443989.0 |
| Oct 10, 2024 | 3.70 | 3.80 | 3.68 | 3.79 | 647135.0 |
| Oct 09, 2024 | 3.77 | 3.78 | 3.70 | 3.76 | 659993.0 |
| Oct 08, 2024 | 3.72 | 3.80 | 3.71 | 3.77 | 387212.0 |
| Oct 07, 2024 | 3.83 | 3.84 | 3.70 | 3.73 | 662595.0 |
| Oct 04, 2024 | 3.91 | 3.92 | 3.81 | 3.84 | 636889.0 |
| Oct 03, 2024 | 3.90 | 3.975 | 3.815 | 3.85 | 719743.0 |
| Oct 02, 2024 | 3.79 | 3.91 | 3.75 | 3.90 | 931769.0 |
| Oct 01, 2024 | 3.81 | 3.84 | 3.65 | 3.83 | 1.211M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.9101
Minimum
Apr 03 2020
6.20
Maximum
Jul 23 2020
2.856
Average
2.81
Median
Feb 04 2020
Price Benchmarks
| Biomarin Pharmaceutical Inc | 65.83 |
| GlycoMimetics Inc | 0.386 |
| FibroGen Inc | 0.3148 |
| Cidara Therapeutics Inc | 13.18 |
| Cue Biopharma Inc | 1.53 |
Price Related Metrics
| PS Ratio | 67.38 |
| Price to Book Value | 5.974 |
| Earnings Yield | -11.61% |
| Market Cap | 731.53M |